TOSHKENT FARMATSEVTIKA INSTITUTI

Tashkent #Ministry of Health of the Republic of Uzbekistan Founded Pharmaceutical Institute in 1937 Rector of Tashkent Pharmaceutical Institute, doctor of medical science, Leaders become professor Kamal Saidakbarovich Rizaev 2023

Tashkent Rector Pharmaceutical Institute of Tashkent Pharmaceutical Institute #2023 Kamal S. Rizaev Doctor of medical Science Professor Our aim is to prepare highly skilled competitive personnel for developing pharmaceutical branch of Independent Uzbekistan. We will do our best to make them mature professionals and perfect human. 2

07 PHARMACY Tashkent Pharmaceutical Institute (CLINICAL PHARMACY) Tashkent Pharmaceutical Institute #History 06 PHARMACY Founded in 16 July in 1937, Tashkent Pharmaceutical (PHARMACEUTICAL ANALYSIS) Institute has gained a significant reputation in pharmaceutical education in the Central Asian and CIS countries thanks to its teaching and research programs. We are proud of our Alumni, they work very successfully and have great career nowadays in occupy high posts in the State and serve as members of Parliament and local councils, research centers, pharmaceutical companies #UNDERGRADUATE 02 METROLOGY, BIOTECHNOLOGY COURSES STANDARDIZATION 03 05(PHARMACEUTICAL BIOTECHNOLOGY) • The Faculty of AND MANAGEMENT 04 PHARMACY Pharmacy OF QUALITY (PHARMACEUTICAL MANAGEMENT) (B.Pharm.-5-year education) OF PRODUCTS • The Faculty of Industrial Pharmacy 05 INDUSTRIAL PHARMACY (B.Pharm.-4-year education) 01 PROFESSIONAL • Uzbek-Russia education EDUCATION faculty (PHARMACY) METROLOGY • Advanced training 3

#Students at Tashkent Pharmaceutical Institute 01 02 #3626 #300 03 Tashkent We enroll more Pharmaceutical Institute than 3626 We have more then 300 TITLE HERE students, among About 40% of our foreign 4 them 3426 are foreign students from students are enrolled in the bachelor, 200 are • Russia 1st year, 35% in the 2nd year master students • India and 25% in the 3rd year • Pakistan • Kazakhstan • Turkmenistan • Kirgizstan • Tajikistan • etc

Tashkent Cooperation with Pharmaceutical Institute over #50 universities INTERNATIONAL #Student's exchange cooperation Training International department #abroad of the university carries out work in the field of integration of the experience of foreign partners in the Tashkent Pharmaceutical Institute

Tashkent Pharmaceutical Institute #2019-2023 Geography of cooperation: the institute cooperates with more than 50 higher educational institutions and research centers in the countries of near and far abroad 95% #HUNGARY #USA Implemented University of RUTGERS into practice Debrecen UNIVERSITY #2023 #China #Korea # Japan #Turkey CHINA HALLYM IRIO SOSEI EGE UNIVERSITY UNIVERSITY PHAMACEUTIAL UNIVERSITY UNIVERSITY

UNIVERSITY of Tashkent Pharmaceutical Institute DEBRECEN #2023 7

# CO-EDUCATION SCIENTIFIC ACTIVITY OF SOP STUDENTS Tashkent Pharmaceutical Institute Joint programs CEPH SCIENTIFIC RESEARCH COMPLEXES Center for Experimental Pharmacology TL DQCC DIRECTIONS OF 5 SCIENTIFIC ACTIVITY Testing laboratory, drug quality control center TASHKENT PHARMACEUTICAL BACHELOR / SPECIALTY INSTITUTE by specialty MSEC MGP \"PHARMACY\" Modern simulation educational complex - GMP training center SAINT PETERSBURG STATE CHEMICAL-PHARMACEUTICAL UNIVERSITY UNIQUENESS OF THE PROJECT SEC MCT training of scientific personnel according to the accelerated training program Scientific and Educational Center for Molecular and Cellular Technologies .0 1 .0 2 LTCL Plant Tissue Culture Laboratory 5 YEARS, Doctorate ACCOMMODATION CONDITIONS FOR SOP STUDENTS INSTEAD OF 7-9 YEARS PhD Dormitory • In accordance w ith the • Graduat es of t his agreem ent \"On t he program have the right - protected area m utual recognition of to continue their e d u cat ion , st udies in PhD - close to university qualifications and - free gym academ ic degrees\", a - free WiFi specialist diplom a is equat ed t o a m ast er's INFRASTRUCTURE degree 2 - for SOP students, separate 2 - in addition to the living rooms, there 2I0n0temrnb1e/st1 100% floors are allocated where AUDIENCES are auditoriums for SOP students to WiFi FLOORS rooms for living are located prepare for classes (Coverage) FOR LESSONS

MAIN INDICATORS IN THE FIELD OF PHARMACEUTICALS BY THE END OF 2022 AND 2023-2026 AND DEVELOPMENT PROSPECTS MAIN INDICATORS OF THE PHARMACEUTICAL NETWORK Results to be achieved in 2023-2026 in network directions Drug manufacturers - 90 Coverage rate of annual demand INVESTMENTS LOCALIZATION SIZE EKSPORT KO'RsAKEYS (in product form) (million.doll (trillion. (mln.doll.) ar) soum.) Manufacturers of medical 80% 360 83 129 3.0 210 - 90devices 60% 190 2.1 4,9 90 55% Medical techniques - 32 manufacturers Production of medicines and - 8 2022y. 2023y. 2026 2022y. 2023y. 2026 2022y. 2023y. 2026 2022y. 2023y. 2026 medical products producers 3, 3,Medicines (trln soums) 1, 1, 1,Medical supplies (trln soums) In other directions (trln soums) INDICATORS 2022 y. 2023 y. 2026 y. 1 3 4, 12 6 1,4 Production volume 4,1 trillion.soum 5,2 trillion.soum 8,2trillion.soum 2 0,5 0,7 Total number of 48 a thousand people 49.3 a thousand 56.2 a thousand items in the field people people 2022y. 2023y. 2026y. 2022y. 2023y. 2026y. 2022y. 2023y. 2026y. LOCALIZATION OF HIGHLY IMPORTED DRUGS NECESSARY MEASURES FOR PROJECT IMPLEMENTATION Neurology drugs Gastrointestinal Blood plasma cardiology, Preparation of 1. Project TIAs, investment portfoliosformation i./ch. diseases based on angiology monoclonal (With the involvement of foreign consulting companies. The costs are covered by the funds of the Agency's drugs i./ch. drugs i./ch. antibodies fund) drugs fori./ch. Project $ 30 Project $ 96 Project $ 35 Project $ 50 2. Preferential creditfunds separate value is Project $ 48 value is value is (annual rate 4-6%, term - 10 years, grace period - 4 years) millio value is million million million Import n value is million Import Import 3. Domestic and foreign investorsto determine size - size - $98 size - $25 $90 Import $139 Import $43 million millio (Attracting competent local and foreign investors) (year 2022) millio size - millio size - millio (year 2022) (year 2022) n 4. Advanced technologiesandInvestmentsattract n (year 2022) n (year 2022) n (with the involvement of leading consulting companies) 5. Localizedto medicinespublic procurementsystem application (by concluding 3-year offset contracts)

Tashkent Pharmaceutical Institute Academic, Administrative and Technical Staff  Full academic staff is more than 347 and 45 part-time employees from other Research Centers - Doctors of science, professors - 47 - Candidates of Science (Ph.D.), associate professors - 97 - Senior teachers - 45 - Assistants - 52  The scientific potential of our academic staff is 52%. Achievements of our scientists  More than 20 synthetic medicinal forms  More than 100 preparations, obtained from medicinal plants

EDUCATIONAL AND PRACTICAL BASE \"CHIMGAN\" IN TIAN-SHAN MOUNTAIN On the educational and practical base \"Chimgan\" students engage with gathering medicinal plants, drying, preparing raw materials and ready - made products. They are brought to the institute's laboratory. In the laboratory, students obtain active substances of medicinal products from herbal plants and carry out research work on the developing medicinal forms.

The Scientific Centre on the Standardization of Medicinal Preparations The Scientific Centre on medicinal preparations standardization equipped with up-to-date apparatus has been organized in the Institute. The main directions of the centre are: the remedies quality control, their standardization, studying specific pharmacological properties, conducting pre-clinical researches, working out the normative-technical documentations for remedies registration on the territory of Uzbekistan. For the short period of time about 10 preparations have been applied into production.

SCIENTIFIC RESEARCH WORK The main directions of research activities in Tashkent Pharmaceutical Institute correspond to the prior lines of pharmaceutical industry development and are concerned with the following scientific problems solving: • Creation of medicines on the basis of local herbs and medicinal plants and introducing them into practice. • Development of new advanced technologies for generic medicines creating. • Improvement of pharmaceutical and toxicological analyses methods. • The marketing and economic analyses of the medicines and medical equipment registered in Uzbekistan • Studying physiologically active agents and dietary supplements and degree of their possible toxicity. 714 works, including the 172 articles and 539 theses, 8 monographs, 3 methodical manuals were published by results of the researches conducted by scientific stuff of the institute in last year. The staff of institute has obtained 4 patents for the invention, 6 patents’ validity period is prolonged, 10 invention applications are claimed to the Agency of intellectual property.

PRIORITIES OF SCIENTIFIC ACTIVITY OF THE INSTITUTE: 1. Creation and implementation to medical practice original medicines on the basis of local medicinal plants and coordination compounds; 2. Development of new advanced technologies of introduced generic drugs; 3. Improvement of methods of pharmaceutical and toxicological analysis; 4. Marketing and pharmacological analysis of registered medicines and medical products in Uzbekistan; 5. Study pharmaco-toxicology of physiologically active substances and biologically active additives.

Educational-research and pilot-production center at TPI 1F-Processing, cleaning, grinding, extraction of plant raw materials 1F-Granulation, capsulation, tablet, packaging, etc 2F-Pre-clinical studies, quality assessment and standardization. Pharmacy-drugstore consisting of 3 parts (cycled one building): 1) Compact Manufacturing Public service drug-store (industrial pharmacy) 2) Phytobar 3) Simulation drug-store (Ready medicines and drug preparation departments)

Ranking of the institute among foreign universities SDG 17 - Strengthening global cooperation for sustainable development (1001+ places, 11.4 points); SDG 5 - Gender equality and empowerment (301+ places, 44.0 points); SDG 3 - promotion of healthy lifestyle and well-being (401+ place, 53.7 points) and SDG 4 - education quality indicators (401+ place, 52.1 points) were considered worthy of places. From September 2, 2021, the Tashkent Pharmaceutical Institute was included in the 2022 ranking of higher education world universities as a \"reporter\". This new status means that it is recognized among universities that have submitted data for an important global ranking, such as the Tashkent Pharmaceutical Institute2022 will be the year to further improve these indicators and achieve higher positions

On June 1, 2023, Times Higher Education, an international university ranking company, published the results of the Impact Ranking 2023.Last year, the Tashkent Pharmaceutical Institute, which took its rightful place among the thirty universities of our Republic, this year was also recognized as one of the leading universities of the Republic. In this rating, the Tashkent Pharmaceutical Institute participated in 5 areas of the rating and took 601+ place in the category \"Good health and well-being\" (SDG 3); 201+ place in the category \"Quality education\" (SDG 4); 401+ place in Gender Equality (SDG 5); 601+ place in the Industrialization, Innovation and Infrastructure category (SDG 9) and 1001+ place in the Partnership for Sustainable Development category (SDG 17). The Institute was awarded 1001+ place in the overall rating with 45.6 points. ������ Tashkent Pharmaceutical Institute has achieved the following results in the ranking for 5 goals: ������ SDG 3 - Good health and well-being - 601 places ������ SDG 4 - Quality education - 201 places ������ SDG 5 - Gender equality - 401 places ������ SDG 9 - Industrialization, innovation and infrastructure - 901 places ������ SDG 17 - Partnership for sustainable development - 1001 places

Thank you Tashkent Pharmaceutical Institute for your attention #2023 Rector 18 of Tashkent Pharmaceutical Institute Kamal S. Rizaev Doctor of medical Science (DSc) Professor contact information